EUVIMEDEUVIMED entdecken
Klinische StudieMultizentrische Studie

Leaving colorectal polyps in situ with endocytoscopy assisted by computer-aided diagnosis: a cost-effectiveness study

Natalie Halvorsen, Ishita Barua iD, Shin-Ei Kudo, Shraddha Gulati, Masashi Misawa iD, Kensaku Mori, Bu'Hussain Hayee iD, Olaolu Olabintan, Jens Aksel Nilsen, Svein Oskar Frigstad, James E East, Amit Rastogi und 7 weitere

Endoscopy · 01.06.2025 · 57 (06) · 611-619

DOI: 10.1055/a-2532-9282 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Endoscopy, erschienen am 01.06.2025. Verfasst von Natalie Halvorsen und 18 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Effectiveness Research Group, University of Oslo, Oslo, Norway. Hauptthemen laut MEDLINE: Adenoma, Colonic Polyps, Colonoscopy, Colorectal Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science http://dx.doi.org/10.13039/501100001691, European Commission http://dx.doi.org/10.13039/501100000780, Japan Society for the Promotion of Sciencehttp://dx.doi.org/10.13039/501100001691.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Computer-aided diagnosis (CADx) enables the distinction between neoplastic and non-neoplastic polyps during colonoscopy. We aimed to estimate the patient-level benefit and harm of CADx.

Methods

We conducted a comparative analysis on data from the EndoBRAIN international clinical trial, evaluating the effect of optical diagnosis during colonoscopy with and without CADx. Three hypothetical scenarios were compared: “endoscopist-alone” and “CADx-assisted” leave-in-situ strategies (leaving non-neoplastic rectosigmoid polyps ≤ 5 mm), and “total removal” (removing all detected polyps). Primary outcomes included patient-level colonoscopy-related cost and surveillance interval agreement (colorectal cancer risk category). Estimates were calculated based on national reimbursement rates and guidelines in four countries.

Results

We analyzed 1134 patients (59 % men, median age 67 years) with 1716 polyps. Compared with total removal, the endoscopist-alone and CADx-assisted leave-in-situ strategies reduced the removed polyps per patient from 1.51 (95 %CI 1.48–1.54) to 1.18 (95 %CI 1.16–1.20) and 1.12 (95 %CI 1.00–1.14), respectively; however, 0.023 (95 %CI 0.015–0.033) and 0.021 (95 %CI 0.014–0.031) neoplasms per patient were left in situ, respectively. The mean colonoscopy cost decreased by $44 (endoscopist alone) and $46 (CADx assistance) in the USA, $22 and $19 in the UK, $21 and $19 in Japan, and $32 and $30 in Norway, respectively. Surveillance interval agreement decreased to 99.2 % (endoscopist alone) and 99.0 % (CADx assistance) in the USA, 99.8 % and 99.8 % in the UK, 97.9 % and 97.1 % in Japan, and 99.9 % and 99.9 % in Norway, respectively.

Conclusions

Both endoscopist-alone and CADx-assisted optical diagnosis reduce colonoscopy costs. The risk of missed adenomas and surveillance interval deviations appear marginal.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenomaColonic PolypsColonoscopyColorectal NeoplasmsDiagnosis, Computer-AssistedAgedFemaleHumansMaleMiddle AgedCost-Benefit Analysis

Autor:innen und Institutionen

  • Clinical Effectiveness Research Group, University of Oslo, Oslo, Norway.
  • Clinical Effectiveness Research Group, Oslo University Hospital, Oslo, Norway.
  • Digestive Disease Center, Showa University Northern Yokohama Hospital, Yokohama, Japan.
  • King's Institute of Therapeutic Endoscopy, King's College Hospital NHS Foundation Trust, London, UK.
  • Graduate School of Informatics, Nagoya University, Nagoya, Japan.
  • Department of Medicine, Baerum Hospital, Vestre Viken Hospital Trust, Gjettum, Norway.

ORCID-Profile: Ishita Barua, Masashi Misawa, Bu'Hussain Hayee, Yuichi Mori

Förderung

  • Japan Society for the Promotion of Science http://dx.doi.org/10.13039/501100001691
  • European Commission http://dx.doi.org/10.13039/501100000780
  • Japan Society for the Promotion of Sciencehttp://dx.doi.org/10.13039/501100001691
  • European Commissionhttp://dx.doi.org/10.13039/501100000780

Zitieren

APA

Halvorsen, N., Barua, I., Kudo, S. E., Gulati, S., Misawa, M., Mori, K., Hayee, B., Olabintan, O., Nilsen, J. A., Frigstad, S. O., East, J. E., Rastogi, A., Hassan, C., Kalager, M., Løberg, M., Holme, Ø., Haji, A., Bretthauer, M., & Mori, Y. (2025). Leaving colorectal polyps in situ with endocytoscopy assisted by computer-aided diagnosis: a cost-effectiveness study. Endoscopy, 57(06), 611-619. https://doi.org/10.1055/a-2532-9282

Vancouver

Halvorsen N, Barua I, Kudo SE, Gulati S, Misawa M, Mori K, et al. Leaving colorectal polyps in situ with endocytoscopy assisted by computer-aided diagnosis: a cost-effectiveness study. Endoscopy. 2025;57(06):611-619. doi:10.1055/a-2532-9282

BibTeX
@article{Halvorsen2025,
  author = {Halvorsen, Natalie and Barua, Ishita and Kudo, Shin-Ei and Gulati, Shraddha and Misawa, Masashi and Mori, Kensaku and Hayee, Bu'Hussain and Olabintan, Olaolu and Nilsen, Jens Aksel and Frigstad, Svein Oskar and East, James E and Rastogi, Amit and Hassan, Cesare and Kalager, Mette and Løberg, Magnus and Holme, Øyvind and Haji, Amyn and Bretthauer, Michael and Mori, Yuichi},
  title = {Leaving colorectal polyps in situ with endocytoscopy assisted by computer-aided diagnosis: a cost-effectiveness study},
  journal = {Endoscopy},
  year = {2025},
  volume = {57},
  number = {06},
  pages = {611--619},
  doi = {10.1055/a-2532-9282}
}
Kostenlos starten →